236 related articles for article (PubMed ID: 34198584)
1. MAGI1, a Scaffold Protein with Tumor Suppressive and Vascular Functions.
Wörthmüller J; Rüegg C
Cells; 2021 Jun; 10(6):. PubMed ID: 34198584
[TBL] [Abstract][Full Text] [Related]
2. MAGI1 localizes to mature focal adhesion and modulates endothelial cell adhesion, migration and angiogenesis.
Alday-Parejo B; Ghimire K; Coquoz O; Albisetti GW; Tamò L; Zaric J; Stalin J; Rüegg C
Cell Adh Migr; 2021 Dec; 15(1):126-139. PubMed ID: 33823745
[TBL] [Abstract][Full Text] [Related]
3. MAGI1 mediates tumor metastasis through c-Myb/miR-520h/MAGI1 signaling pathway in renal cell carcinoma.
Wang W; Yang Y; Chen X; Shao S; Hu S; Zhang T
Apoptosis; 2019 Dec; 24(11-12):837-848. PubMed ID: 31352641
[TBL] [Abstract][Full Text] [Related]
4. MAGI1 Mediates eNOS Activation and NO Production in Endothelial Cells in Response to Fluid Shear Stress.
Ghimire K; Zaric J; Alday-Parejo B; Seebach J; Bousquenaud M; Stalin J; Bieler G; Schnittler HJ; Rüegg C
Cells; 2019 Apr; 8(5):. PubMed ID: 31035633
[TBL] [Abstract][Full Text] [Related]
5. Identification of MAGI1 as a tumor-suppressor protein induced by cyclooxygenase-2 inhibitors in colorectal cancer cells.
Zaric J; Joseph JM; Tercier S; Sengstag T; Ponsonnet L; Delorenzi M; Rüegg C
Oncogene; 2012 Jan; 31(1):48-59. PubMed ID: 21666716
[TBL] [Abstract][Full Text] [Related]
6. MAGI1 as a link between endothelial activation and ER stress drives atherosclerosis.
Abe JI; Ko KA; Kotla S; Wang Y; Paez-Mayorga J; Shin IJ; Imanishi M; Vu HT; Tao Y; Leiva-Juarez MM; Thomas TN; Medina JL; Won JH; Fujii Y; Giancursio CJ; McBeath E; Shin JH; Guzman L; Abe RJ; Taunton J; Mochizuki N; Faubion W; Cooke JP; Fujiwara K; Evans SE; Le NT
JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30944250
[TBL] [Abstract][Full Text] [Related]
7. MAGI1 Prevents Senescence and Promotes the DNA Damage Response in ER
Wörthmüller J; Disler S; Pradervand S; Richard F; Haerri L; Ruiz Buendía GA; Fournier N; Desmedt C; Rüegg C
Cells; 2023 Jul; 12(15):. PubMed ID: 37566008
[TBL] [Abstract][Full Text] [Related]
8. Regulation and involvement in cancer and pathological conditions of MAGI1, a tight junction protein.
Feng X; Jia S; Martin TA; Jiang WG
Anticancer Res; 2014 Jul; 34(7):3251-6. PubMed ID: 24982328
[TBL] [Abstract][Full Text] [Related]
9. MAGI1 inhibits the AMOTL2/p38 stress pathway and prevents luminal breast tumorigenesis.
Kantar D; Mur EB; Mancini M; Slaninova V; Salah YB; Costa L; Forest E; Lassus P; Géminard C; Boissière-Michot F; Orsetti B; Theillet C; Colinge J; Benistant C; Maraver A; Heron-Milhavet L; Djiane A
Sci Rep; 2021 Mar; 11(1):5752. PubMed ID: 33707576
[TBL] [Abstract][Full Text] [Related]
10. MAGI1 recruits Dll1 to cadherin-based adherens junctions and stabilizes it on the cell surface.
Mizuhara E; Nakatani T; Minaki Y; Sakamoto Y; Ono Y; Takai Y
J Biol Chem; 2005 Jul; 280(28):26499-507. PubMed ID: 15908431
[TBL] [Abstract][Full Text] [Related]
11. MiR-486-5p-directed MAGI1/Rap1/RASSF5 signaling pathway contributes to hydroquinone-induced inhibition of erythroid differentiation in K562 cells.
Ma X; Zhang X; Luo J; Liang B; Peng J; Chen C; Guo H; Wang Q; Xing X; Deng Q; Huang H; Liao Q; Chen W; Hu Q; Yu D; Xiao Y
Toxicol In Vitro; 2020 Aug; 66():104830. PubMed ID: 32198055
[TBL] [Abstract][Full Text] [Related]
12. A New Story of the Three Magi: Scaffolding Proteins and lncRNA Suppressors of Cancer.
Kotelevets L; Chastre E
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503076
[TBL] [Abstract][Full Text] [Related]
13. MAGI1, a New Potential Tumor Suppressor Gene in Estrogen Receptor Positive Breast Cancer.
Alday-Parejo B; Richard F; Wörthmüller J; Rau T; Galván JA; Desmedt C; Santamaria-Martinez A; Rüegg C
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31963297
[TBL] [Abstract][Full Text] [Related]
14. MAGI1-IT1 stimulates proliferation in non-small cell lung cancer by upregulating AKT1 as a ceRNA.
Zhang G; Chen HX; Yang SN; Zhao J
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):691-698. PubMed ID: 32016970
[TBL] [Abstract][Full Text] [Related]
15. PTEN gene and integrin signaling in cancer.
Tamura M; Gu J; Tran H; Yamada KM
J Natl Cancer Inst; 1999 Nov; 91(21):1820-8. PubMed ID: 10547389
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
Yamasaki T; Seki N; Yoshino H; Itesako T; Hidaka H; Yamada Y; Tatarano S; Yonezawa T; Kinoshita T; Nakagawa M; Enokida H
J Urol; 2013 Sep; 190(3):1059-68. PubMed ID: 23454155
[TBL] [Abstract][Full Text] [Related]
17. Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion by targeting focal adhesion pathways in cervical squamous cell carcinoma.
Yamamoto N; Kinoshita T; Nohata N; Itesako T; Yoshino H; Enokida H; Nakagawa M; Shozu M; Seki N
Int J Oncol; 2013 May; 42(5):1523-32. PubMed ID: 23483249
[TBL] [Abstract][Full Text] [Related]
18. Differences in integrin expression and signaling within human breast cancer cells.
Taherian A; Li X; Liu Y; Haas TA
BMC Cancer; 2011 Jul; 11():293. PubMed ID: 21752268
[TBL] [Abstract][Full Text] [Related]
19. Mutational analysis of WTX gene in Wnt/ beta-catenin pathway in gastric, colorectal, and hepatocellular carcinomas.
Yoo NJ; Kim S; Lee SH
Dig Dis Sci; 2009 May; 54(5):1011-4. PubMed ID: 18720004
[TBL] [Abstract][Full Text] [Related]
20. TTPAL Promotes Colorectal Tumorigenesis by Stabilizing TRIP6 to Activate Wnt/β-Catenin Signaling.
Gou H; Liang JQ; Zhang L; Chen H; Zhang Y; Li R; Wang X; Ji J; Tong JH; To KF; Sung JJY; Chan FKL; Fang JY; Yu J
Cancer Res; 2019 Jul; 79(13):3332-3346. PubMed ID: 31018940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
